Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.102)

81

Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022 : an interim analysis using the French JIR cohort database

enthalten in: Arthritis research & therapy | 2024

von Koné-Paut, I. | Georgin-Lavialle, S. | Belot, A. | +5

82

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus : A Post Hoc Analysis of the EXCEED-BHS3 Trial

enthalten in: International journal of molecular sciences | 2024

von Bonilha, I. | Gomes, �. | Carmo, H. | +13

83

Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Cancer reports (Hoboken, N.J.) | 2024

von Ohama, H. | Hiraoka, A. | Tada, T. | +42

84

Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma : a prospective phaseⅡstudy

enthalten in: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery | 2024

von Chen, X. | Xie, Z. | Lu, H. | +2

85

Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2-expressing salivary gland carcinoma : a pooled analysis of two phase I studies

enthalten in: Japanese journal of clinical oncology | 2024

von Takahashi, S. | Bando, H. | Kinoshita, I. | +9

86

A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer : insights from ProMisE molecular classification system

enthalten in: Japanese journal of clinical oncology | 2024

von Chiba, Y. | Kagabu, M. | Osakabe, M. | +8

87

A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

enthalten in: Clinical genitourinary cancer | 2024

von Boiarsky, D. | Gulhan, D. | Savignano, H. | +10

88

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18) : a randomised, double-blind, phase 3 clinical trial

enthalten in: Lancet (London, England) | 2024

von Lorusso, D. | Xiang, Y. | Hasegawa, K. | +32

89

Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer : a real-world retrospective single-institutional study in China

enthalten in: World journal of surgical oncology | 2024

von Peng, D. | Li, J. | Qiu, J. | +1

90

Varicella zoster virus reactivation reported with isatuximab use

enthalten in: Journal of chemotherapy (Florence, Italy) | 2024

von Nadeau Nguyen, M. | Dores, G. | Nayernama, A. | +1